Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1969 2
1970 2
1971 4
1972 3
1973 4
1974 5
1975 1
1976 2
1977 8
1978 6
1979 4
1980 2
1981 6
1982 5
1983 4
1984 3
1985 6
1986 2
1987 5
1988 4
1989 9
1990 9
1991 5
1992 10
1993 5
1994 9
1995 12
1996 16
1997 31
1998 23
1999 32
2000 33
2001 29
2002 49
2003 48
2004 44
2005 53
2006 50
2007 60
2008 55
2009 55
2010 64
2011 78
2012 82
2013 86
2014 86
2015 98
2016 99
2017 104
2018 92
2019 93
2020 115
Text availability
Article attribute
Article type
Publication date

Search Results

1,555 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis C virus infection and risk of Parkinson's disease: a systematic review and meta-analysis.
Wijarnpreecha K, Chesdachai S, Jaruvongvanich V, Ungprasert P. Wijarnpreecha K, et al. Eur J Gastroenterol Hepatol. 2018 Jan;30(1):9-13. doi: 10.1097/MEG.0000000000000991. Eur J Gastroenterol Hepatol. 2018. PMID: 29049127 Review.
BACKGROUND/OBJECTIVE: Hepatitis C virus (HCV) infection is one of the most common infections worldwide. Recent epidemiologic studies have suggested that patients with HCV infection might be at an increased risk of Parkinson's disease. ...Studies that r …
BACKGROUND/OBJECTIVE: Hepatitis C virus (HCV) infection is one of the most common infections worldwide. Recent epidemiologic studies …
Parkinson's disease: a dual-hit hypothesis.
Hawkes CH, Del Tredici K, Braak H. Hawkes CH, et al. Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614. doi: 10.1111/j.1365-2990.2007.00874.x. Epub 2007 Oct 24. Neuropathol Appl Neurobiol. 2007. PMID: 17961138 Free PMC article. Review.
Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-motor features develop, in particular, impairment of olfaction, vagal dysfunction and sleep disorder. ...It is concluded that the most parsim …
Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-m …
Evidence for association between hepatitis C virus and Parkinson's disease.
Abushouk AI, El-Husseny MWA, Magdy M, Ismail A, Attia A, Ahmed H, Pallanti R, Negida A. Abushouk AI, et al. Neurol Sci. 2017 Nov;38(11):1913-1920. doi: 10.1007/s10072-017-3077-4. Epub 2017 Aug 5. Neurol Sci. 2017. PMID: 28780707 Review.
Parkinson's disease (PD) is a globally prevalent neurodegenerative disorder, characterized by progressive neuronal loss in the substantia nigra and formation of Lewy bodies. ...Emerging data from epidemiological studies suggest a possible association between
Parkinson's disease (PD) is a globally prevalent neurodegenerative disorder, characterized by progressive neuronal loss
Disease-modifying strategies for Parkinson's disease.
Kalia LV, Kalia SK, Lang AE. Kalia LV, et al. Mov Disord. 2015 Sep 15;30(11):1442-50. doi: 10.1002/mds.26354. Epub 2015 Jul 24. Mov Disord. 2015. PMID: 26208210 Review.
Parkinson's disease (PD) is an increasingly prevalent and progressively disabling neurodegenerative disease. The impact of PD on patients and their families as well as its burden on health care systems could be substantially reduced by disease-m
Parkinson's disease (PD) is an increasingly prevalent and progressively disabling neurodegenerative disease. The
Axon degeneration in Parkinson's disease.
Burke RE, O'Malley K. Burke RE, et al. Exp Neurol. 2013 Aug;246:72-83. doi: 10.1016/j.expneurol.2012.01.011. Epub 2012 Jan 18. Exp Neurol. 2013. PMID: 22285449 Free PMC article. Review.
Parkinson's disease (PD) is the most common neurodegenerative disease of the basal ganglia. Like other adult-onset neurodegenerative disorders, it is without a treatment that forestalls its chronic progression. ...We review evidence from human post-mor
Parkinson's disease (PD) is the most common neurodegenerative disease of the basal ganglia. Like other adult-ons
Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain.
Thakur P, Breger LS, Lundblad M, Wan OW, Mattsson B, Luk KC, Lee VMY, Trojanowski JQ, Björklund A. Thakur P, et al. Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8284-E8293. doi: 10.1073/pnas.1710442114. Epub 2017 Sep 12. Proc Natl Acad Sci U S A. 2017. PMID: 28900002 Free PMC article.
Although a causative role of α-synuclein (α-syn) is well established in Parkinson's disease pathogenesis, available animal models of synucleinopathy do not replicate the full range of cellular and behavioral changes characteristic of the human disease. …
Although a causative role of α-synuclein (α-syn) is well established in Parkinson's disease pathogenesis, available ani …
GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
Springer AD, Dowdy SF. Springer AD, et al. Nucleic Acid Ther. 2018 Jun;28(3):109-118. doi: 10.1089/nat.2018.0736. Epub 2018 May 24. Nucleic Acid Ther. 2018. PMID: 29792572 Free PMC article. Review.
Short-interfering RNA (siRNA)-induced RNAi responses have great potential to treat a wide variety of human diseases from cancer to pandemic viral outbreaks to Parkinson's Disease. ...
Short-interfering RNA (siRNA)-induced RNAi responses have great potential to treat a wide variety of human diseases from cancer to pandemic …
Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U. Bedarf JR, et al. Genome Med. 2017 Apr 28;9(1):39. doi: 10.1186/s13073-017-0428-y. Genome Med. 2017. PMID: 28449715 Free PMC article.
BACKGROUND: Parkinson's disease (PD) presently is conceptualized as a protein aggregation disease in which pathology involves both the enteric and the central nervous system, possibly spreading from one to another via the vagus nerves. ...While the abu …
BACKGROUND: Parkinson's disease (PD) presently is conceptualized as a protein aggregation disease in which patho …
Striatal cholinergic interneurons and Parkinson's disease.
Tanimura A, Pancani T, Lim SAO, Tubert C, Melendez AE, Shen W, Surmeier DJ. Tanimura A, et al. Eur J Neurosci. 2018 May;47(10):1148-1158. doi: 10.1111/ejn.13638. Epub 2017 Jul 20. Eur J Neurosci. 2018. PMID: 28677242 Free PMC article. Review.
In recent years, new experimental approaches, like optogenetics and monosynaptic rabies virus mapping, have expanded our understanding of how ChIs contribute to the striatal activity underlying action selection and the interplay of dopaminergic and cholinergic signaling. T …
In recent years, new experimental approaches, like optogenetics and monosynaptic rabies virus mapping, have expanded our understandin …
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.
Palfi S, Gurruchaga JM, Lepetit H, Howard K, Ralph GS, Mason S, Gouello G, Domenech P, Buttery PC, Hantraye P, Tuckwell NJ, Barker RA, Mitrophanous KA. Palfi S, et al. Hum Gene Ther Clin Dev. 2018 Sep;29(3):148-155. doi: 10.1089/humc.2018.081. Hum Gene Ther Clin Dev. 2018. PMID: 30156440 Free PMC article. Clinical Trial.
Parkinson's disease is typically treated with oral dopamine replacement therapies. However, long-term use is complicated by motor fluctuations from intermittent stimulation of dopamine receptors and off-target effects. ...Here, patients with Parkinson'
Parkinson's disease is typically treated with oral dopamine replacement therapies. However, long-term use is complicate
1,555 results
Jump to page
Feedback